About this trial
Cardiopulmonary bypass (CPB) is a critical technology in cardiac surgery, allowing for the temporary replacement of the heart and lung functions during intricate surgical procedures. it has significant post-surgical complications, the most important complications of CPB is right ventricle (RV) dysfunction. Diagnosis and management of RV dysfunction is crucial for maintenance of hemodynamic stability and organ function in early post-operation period and prognostic for later phase.
Eligibility criteria
Qualifiers
American Society of Anesthesiologists (ASA) physical status II & III
Age between 18 and 70 years
Both Gender
Body mass index less than 40 kg/m2
Disqualifiers
Patient refusal.
Preoperative RV impairment
Pulmonary hypertension (estimated pulmonary artery systolic pressure > 50 mmHg)
Patients with any contraindications to Transesophageal echocardiography (TEE)
Trial design
Treatments tested in this trial
- Epinephrine
- Milrinone Injection